JPS5512425B1 - - Google Patents
Info
- Publication number
- JPS5512425B1 JPS5512425B1 JP2765271A JP2765271A JPS5512425B1 JP S5512425 B1 JPS5512425 B1 JP S5512425B1 JP 2765271 A JP2765271 A JP 2765271A JP 2765271 A JP2765271 A JP 2765271A JP S5512425 B1 JPS5512425 B1 JP S5512425B1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/50—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
- C07D241/52—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3487170A | 1970-05-05 | 1970-05-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPS5512425B1 true JPS5512425B1 (ja) | 1980-04-02 |
Family
ID=21879114
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2765271A Pending JPS5512425B1 (ja) | 1970-05-05 | 1971-04-28 | |
| JP13168879A Granted JPS5559174A (en) | 1970-05-05 | 1979-10-12 | Manufacture of 33substituted methylquinoxalinee22carboxyamidoo1*44dioxide |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13168879A Granted JPS5559174A (en) | 1970-05-05 | 1979-10-12 | Manufacture of 33substituted methylquinoxalinee22carboxyamidoo1*44dioxide |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3644360A (ja) |
| JP (2) | JPS5512425B1 (ja) |
| BE (1) | BE805310Q (ja) |
| BR (1) | BR7102451D0 (ja) |
| CA (1) | CA981267A (ja) |
| DE (1) | DE2120501C3 (ja) |
| FR (1) | FR2092131B1 (ja) |
| GB (1) | GB1291625A (ja) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4039540A (en) * | 1974-05-07 | 1977-08-02 | Pfizer Inc. | 3-Substituted quinoxaline-2-carboxamide-1,4-dioxides |
| IE40886B1 (en) * | 1974-05-07 | 1979-09-12 | Pfizer | 3-substituted quinoxaline-2-carboxamide-1,4-dioxides |
| CN103664807A (zh) * | 2013-12-02 | 2014-03-26 | 河北美荷药业有限公司 | 3-甲基-2-（甲氧基苯乙烯酮基）-喹喔啉-1，4-二氧化物及其制备方法和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1325581A (en) * | 1969-07-22 | 1973-08-01 | Pfizer | 3-methyl-2-quinoxalinecarboxamide-di-n-oxides |
-
1970
- 1970-05-05 US US34871A patent/US3644360A/en not_active Expired - Lifetime
- 1970-07-29 GB GB36809/70A patent/GB1291625A/en not_active Expired
-
1971
- 1971-04-14 CA CA110,286A patent/CA981267A/en not_active Expired
- 1971-04-26 BR BR2451/71A patent/BR7102451D0/pt unknown
- 1971-04-27 DE DE2120501A patent/DE2120501C3/de not_active Expired
- 1971-04-28 FR FR7115184A patent/FR2092131B1/fr not_active Expired
- 1971-04-28 JP JP2765271A patent/JPS5512425B1/ja active Pending
-
1973
- 1973-09-26 BE BE1005385A patent/BE805310Q/xx not_active IP Right Cessation
-
1979
- 1979-10-12 JP JP13168879A patent/JPS5559174A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5550025B2 (ja) | 1980-12-16 |
| JPS5559174A (en) | 1980-05-02 |
| DE2120501C3 (de) | 1980-08-21 |
| FR2092131B1 (ja) | 1974-08-30 |
| US3644360A (en) | 1972-02-22 |
| CA981267A (en) | 1976-01-06 |
| FR2092131A1 (ja) | 1972-01-21 |
| DE2120501A1 (de) | 1971-11-25 |
| DE2120501B2 (de) | 1979-12-20 |
| BR7102451D0 (pt) | 1973-07-17 |
| BE805310Q (fr) | 1974-01-16 |
| GB1291625A (en) | 1972-10-04 |